Stock Price
0.47
Daily Change
0.06 13.41%
Monthly
-3.13%
Yearly
365.00%
Q1 Forecast
0.40

Starpharma Holdings reported AUD4.42M in Selling and Administration Expenses for its fiscal semester ending in December of 2025.





Selling And Administration Expenses Change Date
Medical Developments International AUD 2.84M 4.19M Dec/2025
Mesoblast USD 28.54M 9.69M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025